New Mexico 2024 Regular Session Status: Enacted 2 R cosponsors

HM 3 — PRENATAL SUBSTANCE EXPOSURE TASK FORCE

Last action — Signed

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 10, 2024. Enacted.

Signed by Governor Michelle Lujan Grisham (Democratic) on February 22, 2024.

Prognosis

Advancing 56% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 3 sponsors

    3 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (2 R).

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

What changed in the latest version

187 added · 252 removed

Plain-language change summary

The latest version of House Memorial 3 adds a clear request for the Secretary of Health to form a task force aimed at studying prenatal substance exposure and its effects. This matters because New Mexico faces alarming rates of substance exposure among newborns, which can lead to significant health and developmental challenges for infants. The study will provide valuable information to help address this pressing issue and develop strategies for better maternal and infant health outcomes in the state.

→
Previous
Latest
HOUSE MEMORIAL 3 56TH LEGISLATURE- STATE OF NEWMEXICO - SECOND SESSION, 2024 INTRODUCED BY Stefani Lord and Jenifer Jones and Tara Jaramillo 6 8 10 A MEMORIAL REQUESTING THE SECRETARY OF HEALTH TO CONVENE A TASK FORCE TO STUDY THE PREVALENCE, EFFECTS AND LIFETIME FISCAL IMPACTS OF PRENATAL SUBSTANCE EXPOSURE AND ADVERSE NEONATAL OUTCOMES;
A MEMORIAL REQUESTING THE SECRETARY OF HEALTH TO CONVENE A TASK FORCE TO STUDY THE PREVALENCE, EFFECTS AND LIFETIME FISCAL IMPACTS OF PRENATAL SUBSTANCE EXPOSURE AND ADVERSE NEONATAL OUTCOMES;
e t 17 WHEREAS, more than one thousand two hundred children are w l n d 18 born in New Mexico each year, with nearly one in ten live = = 19 a l births being substance-exposed, one of the highest substance i a e r 20 exposure rates in the country;
8 WHEREAS, more than one thousand two hundred children are born in New Mexico each year, with nearly one in ten live births being substance-exposed, one of the highest substance exposure rates in the country;
and a t m m 21 WHEREAS, the number of New Mexico newborns exposed to d r e 22 addictive substances in utero increased three hundred twenty- c e s k 23 four percent between 2008 and 2017, and infants born exposed to e a n b 24 addictive substances may struggle with health, learning and u [ social challenges throughout their lives;
and WHEREAS, the number of New Mexico newborns exposed to addictive substances in utero increased three hundred twenty- four percent between 2008 and 2017, and infants born exposed to addictive substances may struggle with health, learning and social challenges throughout their lives;
and .226525.2 WHEREAS, New Mexico is currently experiencing a crisis in the rise of fentanyl use and fentanyl pediatric exposure and record numbers of overdoses;
and WHEREAS, New Mexico is currently experiencing a crisis in the rise of fentanyl use and fentanyl pediatric exposure and record numbers of overdoses;
low birth weight, premature birth, vision and hearing loss, fine and gross motor development delays, sensory processing disorders, cognitive issues related to executive functioning, gastrointestinal tract and reflux issues and impaired pain sensation;
low birth weight, premature birth, vision and hearing loss, fine and gross motor development delays, sensory processing disorders, cognitive issues related to executive functioning, gastrointestinal HM 3 Page 1 tract and reflux issues and impaired pain sensation;
and WHEREAS, since 2018, the United States children's bureau has collected information on the number of substance-exposed e t 17 infants and service referrals made;
and WHEREAS, since 2018, the United States children's bureau has collected information on the number of substance-exposed infants and service referrals made;
and w l n d 18 WHEREAS, in 2019, New Mexico instituted the federal = = 19 a l Comprehensive Addiction and Recovery Act of 2016 plan of safe i a e r 20 care program to keep mothers and babies together with a t m m 21 supportive services;
and WHEREAS, in 2019, New Mexico instituted the federal Comprehensive Addiction and Recovery Act of 2016 plan of safe care program to keep mothers and babies together with supportive services;
and d r e 22 WHEREAS, according to the children, youth and families c e s k 23 department, from 2020 to 2021, nine infants with a plan of safe e a n b 24 care or notification died within their first year, and many of u [ those cases were also reported for child abuse;
and WHEREAS, according to the children, youth and families department, from 2020 to 2021, nine infants with a plan of safe care or notification died within their first year, and many of those cases were also reported for child abuse;
and .226525.2 - 2 - WHEREAS, early identification and intervention reduce adverse outcomes of prenatal substance use, but stigma, shame and fear of legal ramifications deter women from seeking prenatal care;
and WHEREAS, early identification and intervention reduce adverse outcomes of prenatal substance use, but stigma, shame and fear of legal ramifications deter women from seeking prenatal care;
NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES OF THE STATE OF NEW MEXICO that the secretary of health be requested to convene a task force to make recommendations and to study the effects of prenatal drug exposure on birth outcomes for children in New Mexico;
NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES OF THE STATE OF NEW MEXICO that the secretary HM 3 Page 2 of health be requested to convene a task force to make recommendations and to study the effects of prenatal drug exposure on birth outcomes for children in New Mexico;
study the efficacy and outcomes of the state's 2019 adoption of the federal Comprehensive Addiction and e t 17 Recovery Act of 2016 plan of safe care and ongoing w l n d 18 implementation;
study the efficacy and outcomes of the state's 2019 adoption of the federal Comprehensive Addiction and Recovery Act of 2016 plan of safe care and ongoing implementation;
= = 19 a l B.
B.
review rates of the use of prenatal services and i a e r 20 support by mothers who used drugs during pregnancy before the a t m m 21 passage of the 2019 adoption of the federal Comprehensive d r e 22 Addiction and Recovery Act of 2016 plan of safe care and since c e s k 23 its implementation;
review rates of the use of prenatal services and support by mothers who used drugs during pregnancy before the passage of the 2019 adoption of the federal Comprehensive Addiction and Recovery Act of 2016 plan of safe care and since its implementation;
e a n b 24 C.
C.
conduct a longitudinal study on rates of u [ substance-exposed newborns in New Mexico over the last twenty .226525.2 - 3 - years;
conduct a longitudinal study on rates of substance-exposed newborns in New Mexico over the last twenty years;
study and develop recommendations for the prevention, identification and treatment of neonatal abstinence syndrome;
study and develop recommendations for the HM 3 Page 3 prevention, identification and treatment of neonatal abstinence syndrome;
conduct a review of ways that other states e t 17 implement plans of safe care;
conduct a review of ways that other states implement plans of safe care;
w l n d 18 J.
J.
conduct a review of states in which prenatal = = 19 a l substance exposure constitutes a substantiated child abuse i a e r 20 claim and subsequent intervention;
conduct a review of states in which prenatal substance exposure constitutes a substantiated child abuse claim and subsequent intervention;
a t m m 21 K.
K.
explore the provision of preventive services d r e 22 through community health workers;
explore the provision of preventive services through community health workers;
c e s k 23 L.
L.
conduct a comprehensive nationwide best practice e a n b 24 review on evidence-based plans to reduce prenatal substance u [ exposure;
conduct a comprehensive nationwide best practice review on evidence-based plans to reduce prenatal substance exposure;
.226525.2 - 4 - M.
M.
study and provide recommendations on the feasibility of statewide prenatal substance screening;
study and provide recommendations on the HM 3 Page 4 feasibility of statewide prenatal substance screening;
study what follow-up services are available to e t 17 families in other states once a newborn who was exposed to w l n d 18 prenatal substance abuse has been discharged from the hospital;
study what follow-up services are available to families in other states once a newborn who was exposed to prenatal substance abuse has been discharged from the hospital;
= = 19 a l and i a e r 20 BE IT FURTHER RESOLVED that the task force be requested to a t m m 21 develop a data-driven implementation plan, focusing on d r e 22 preventing prenatal opioid exposure, providing evidence-based c e s k 23 treatment for both mothers and infants, increasing the e a n b 24 accessibility of services for pregnant and parenting women with u [ substance use disorder, supporting continuing education for .226525.2 - 5 - health care providers and determining effective family and developmental support services for children who have experienced prenatal substance exposure;
and BE IT FURTHER RESOLVED that the task force be requested to develop a data-driven implementation plan, focusing on preventing prenatal opioid exposure, providing evidence-based treatment for both mothers and infants, increasing the accessibility of services for pregnant and parenting women with substance use disorder, supporting continuing education for health care providers and determining effective family and developmental support services for children who have experienced prenatal substance exposure;
a representative of the 2021 New Mexico department of health evaluation team of the 2021 Comprehensive Addiction and Recovery Act of 2016;
a representative of the 2021 New Mexico HM 3 Page 5 department of health evaluation team of the 2021 Comprehensive Addiction and Recovery Act of 2016;
representation from the children, youth and families department, the department of health, the health care e t 17 authority department and the early childhood education and care w l n d 18 department;
representation from the children, youth and families department, the department of health, the health care authority department and the early childhood education and care department;
= = 19 a l F.
F.
a first responder with emergency medical i a e r 20 services experience;
a first responder with emergency medical services experience;
a t m m 21 G.
G.
experts with experience in medicaid managed care d r e 22 organizations;
experts with experience in medicaid managed care organizations;
c e s k 23 H.
H.
an expert with experience in hospital e a n b 24 management;
an expert with experience in hospital management;
u [ I.
I.
.226525.2 - 6 - J.
J.
O.
HM 3 Page 6 O.
and e t 17 BE IT FURTHER RESOLVED that those findings and w l n d 18 recommendations of the task force be presented to the = = 19 a l legislative health and human services committee by August 1, i a e r 20 2025;
and BE IT FURTHER RESOLVED that those findings and recommendations of the task force be presented to the legislative health and human services committee by August 1, 2025;
and a t m m 21 BE IT FURTHER RESOLVED that copies of this memorial be d r e 22 transmitted to the governor, the attorney general, the chair of c e s k 23 the legislative health and human services committee, the e a n b 24 director of the legislative finance committee, the appropriate u [ cabinet secretaries and the director of the children's cabinet.
and BE IT FURTHER RESOLVED that copies of this memorial be transmitted to the governor, the attorney general, the chair of the legislative health and human services committee, the director of the legislative finance committee, the appropriate cabinet secretaries and the director of the children's cabinet.
Show all 41 changed rows (1 more)
Previous
Latest
.226525.2 - 7 -
HM 3 Page 7 25
View plain text versions (2)

Action History

  1. Signed

  2. passed House

  3. DO PASS committee report adopted

  4. Sent to House Health & Human Services Committee

  5. Sent to House Pre-file

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

3 sponsors · 0 co-sponsors · 109 not signed on

Sponsors (3)

Co-sponsors (0)

None.

Not signed on (109)

109 members have not signed on to this bill.

Show all 109 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HM 3?
HM 3 is sponsored by Jaramillo, Tara, Stefani Lord (Republican), and Jenifer Jones (Republican).
What is the current status of HM 3?
This bill has been enacted into law. Introduced January 10, 2024. Enacted.
Where can I track HM 3?
Track HM 3 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HM 3

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HM 3

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →